Alligator Bioscience AB
ALLI.STN/A
NASDAQBiotechnology🇺🇸North America
Drugs in Pipeline
1
Phase 3 Programs
0
Upcoming Catalysts
1
Next Catalyst
Jun 1, 2026
11wMarket Overview
Stock performance and key metrics
ALLI.ST News
Catalyst Timeline
1 upcoming, 0 past
Drug Pipeline
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
CD40 agonist mitazalimab in combination with chemotherapy | Phase 2 | Metastatic Pancreatic Ductal Adenocarcinoma | - | - |
Regulatory Approvals
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply